Topics

Julie Levy

Thu, 09 Oct 2008 11:35:25 -0700

by Peter Severinson

In the genes

Tue, 01 Apr 2008 16:30:00 -0700

by Claudia Cornwall

When Michael Hayden was a doctor at Children’s Hospital Boston, a teaching arm of Harvard Medical School, he did the unthinkable: he left – for a position at UBC. “When I told people in Boston and Harvard, they thought I was crazy. Some suggested I see a psychiatrist. They said I was committing academic suicide – I’d lost it.”
But going his own way has paid off.

When labs attack

Sat, 01 Mar 2008 01:04:00 -0800

By Peter Severinson

“One of the things I realized about business is that they’re not as friendly as scientists,” says Genetrack president and CEO June Wong.
“This is a battleground. It’s not always about whose product is the best, it’s not about who’s the most honest; it’s really about competitors killing you.”

Starstudded start-up

Fri, 01 Sep 2006 17:58:51 -0700

By Jessica Werb

A little-known Richmond biotech company has just received Health Canada approval for an HIV test that works in 60 seconds using a small drop of blood. That’s newsworthy enough. But check out its roster of investors: Markus Naslund and a slew of other NHLers (not to mention the entire cast of Nickelback and local shipping tycoon Kyle Washington). Scoring big points for star quality is one thing, but can the company’s rapid HIV test live up to its promises?

Biotech breakthrough

Sat, 01 Jul 2006 09:07:51 -0700

By David Jordan

The Dark Horse of the Year award goes to Aspreva Pharmaceuticals. This young biotech shot out of the gate to not only crack the Top 100 public companies list just four years after its inception, but also claim bragging rights as the only biotech in B.C. to record a profit in 2005.